candoxatril has been researched along with glucagon in 2 studies
| Studies (candoxatril) | Trials (candoxatril) | Recent Studies (post-2010) (candoxatril) | Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) |
|---|---|---|---|---|---|
| 62 | 29 | 5 | 26,039 | 1,498 | 3,054 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carr, RD; Deacon, CF; Holst, JJ; Klarskov, L; Olesen, M; Trebbien, R | 1 |
| Carr, RD; Deacon, CF; Holst, JJ; Plamboeck, A | 1 |
2 other study(ies) available for candoxatril and glucagon
| Article | Year |
|---|---|
Neutral endopeptidase 24.11 is important for the degradation of both endogenous and exogenous glucagon in anesthetized pigs.
Topics: Animals; Drug Synergism; Glucagon; Indans; Infusions, Intravenous; Neprilysin; Osmolar Concentration; Propionates; Protease Inhibitors; Radioimmunoassay; Swine | 2004 |
Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig.
Topics: Animals; Antihypertensive Agents; Area Under Curve; Dipeptidyl Peptidase 4; Glucagon; Indans; Insulin; Metabolic Clearance Rate; Models, Animal; Neprilysin; Propionates; Swine | 2005 |